← back to search

Siegfried Priglinger

Ludwig-Maximilians-Universität München · DE
Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Ophthalmology and Genetic enhancement, with related work in Guideline, Visual acuity, Cornea. Notable publications include 'Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders', 'Central serous chorioretinopathy: An evidence-based treatment guideline', and 'Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis'.
h-index
citations
326
works
8
NIH funding
primary concept
email

Recent publications

Central serous chorioretinopathy: An evidence-based treatment guideline
Progress in Retinal and Eye Research 2024cited by 112position: middledoi
Anatomic Outcomes with Faricimab vs Aflibercept in Head-to-Head Dosing Phase of the TENAYA/LUCERNE Trials in Neovascular Age-related Macular Degeneration
Ophthalmology 2024cited by 13position: middledoi
UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial
Trials 2024cited by 7position: middledoi
Gene Therapy with Voretigene Neparvovec Improves Vision and Partially Restores Electrophysiological Function in Pre-School Children with Leber Congenital Amaurosis
Biomedicines 2022cited by 31position: lastdoi
Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders
EMBO Molecular Medicine 2021cited by 130position: middledoi
<i>Ex vivo</i> excimer laser ablation of cornea guttata and ROCK inhibitor‐aided endothelial recolonization of ablated central cornea
Acta Ophthalmologica 2020cited by 16position: middledoi
Norrin Protects Retinal Ganglion Cells from Excitotoxic Damage via the Induction of Leukemia Inhibitory Factor
Cells 2020cited by 12position: middledoi
Endogenous Wnt/β-catenin signaling in Müller cells protects retinal ganglion cells from excitotoxic damage.
PubMed 2020cited by 5position: middle

Grants

No grants ingested yet.

Frequent collaborators

Andreas Ohlmann · University of Regensburg3 papers (2020–2020)Rudolf Fuchshofer · University of Regensburg3 papers (2020–2020)Maximilian Gerhardt · Ludwig-Maximilians-Universität München2 papers (2021–2022)Stylianos Michalakis · Ludwig-Maximilians-Universität München2 papers (2021–2022)Stefan Kassumeh · Ludwig-Maximilians-Universität München2 papers (2020–2020)Ernst R. Tamm · University of Regensburg2 papers (2020–2020)Claus Cursiefen · Friedrich-Alexander-Universität Erlangen-Nürnberg1 papers (2024–2024)Berthold Seitz · University Hospital of Basel1 papers (2024–2024)Martin Biel · Ludwig-Maximilians-Universität München1 papers (2021–2021)Gerd Geerling · Augenklinik Heidelberg1 papers (2024–2024) · 1 papers (2020–2020)Philippe Margaron · Novartis (Switzerland)1 papers (2024–2024) · 1 papers (2024–2024)Roswitha Seitz · University of Regensburg1 papers (2020–2020)Ryan F. Boyd · Michigan State University1 papers (2021–2021)Gregor R. Weber · University of Regensburg1 papers (2020–2020)Gregory Moloney · University of British Columbia Hospital1 papers (2020–2020)Johanna Wagner · Ludwig-Maximilians-Universität München1 papers (2021–2021) · 1 papers (2024–2024)Nadja Meumann · Medizinische Hochschule Hannover1 papers (2021–2021)